Literature DB >> 1511745

Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease.

J Bednarek1, J Furmaniak, N Wedlock, Y Kiso, A Baumann-Antczak, S Fowler, H Krishnan, J A Craft, B Rees Smith.   

Abstract

An adrenal-specific protein reacting with autoantibodies in the sera of patients with adult onset Addison's disease has been purified from human adrenal glands. The protein, mol.wt. 55K, has the biochemical characteristics of steroid 21-hydroxylase and reacts on Western blots with rabbit antibodies to recombinant 21-hydroxylase. Absorption of the native human 55K adrenal protein with human adrenal autoantibodies prevented the subsequent reaction of the 55K protein with rabbit antibodies to 21-hydroxylase in Western blot analysis. In addition, human adrenal autoantibodies reacted with recombinant 21-hydroxylase expressed in yeast. These data indicate that the adrenal specific enzyme steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511745     DOI: 10.1016/0014-5793(92)80737-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Screening of endocrine organ-specific humoral autoimmunity in 47,XXY Klinefelter's syndrome reveals a significant increase in diabetes-specific immunoreactivity in comparison with healthy control men.

Authors:  Francesca Panimolle; Claudio Tiberti; Simona Granato; Antonella Semeraro; Daniele Gianfrilli; Antonella Anzuini; Andrea Lenzi; Antonio Radicioni
Journal:  Endocrine       Date:  2015-05-03       Impact factor: 3.633

3.  A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease.

Authors:  M Volpato; L Prentice; S Chen; C Betterle; B Rees Smith; J Furmaniak
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease.

Authors:  Z El Ali; M Fichna; J Piniewska; J Kosowicz; M Grzymisławski
Journal:  J Endocrinol Invest       Date:  2009-09-30       Impact factor: 4.256

Review 5.  Therapy of adrenal insufficiency: an update.

Authors:  Alberto Falorni; Viviana Minarelli; Silvia Morelli
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

6.  Mapping of B cell epitopes on steroid 17 alpha-hydroxylase, an autoantigen in autoimmune polyglandular syndrome type I.

Authors:  P Peterson; K J Krohn
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

Review 7.  Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults.

Authors:  C Betterle; F Presotto; J Furmaniak
Journal:  J Endocrinol Invest       Date:  2019-07-18       Impact factor: 5.467

Review 8.  Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence.

Authors:  Roberto Perniola; Alessandra Fierabracci; Alberto Falorni
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

9.  Autoantibodies against Cytochrome P450 Side-Chain Cleavage Enzyme in Dogs (Canis lupus familiaris) Affected with Hypoadrenocorticism (Addison's Disease).

Authors:  Alisdair M Boag; Michael R Christie; Kerry A McLaughlin; Harriet M Syme; Peter Graham; Brian Catchpole
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.